2m 2m 2m 2m 2m 2m 2m
Bespoke Extrcts (BSPK)
OTC
$0.0006+$0.0001 (+20.20%)
Price as of Nov 09, 2026- $2.6MMarket Cap
- -99.54%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Bespoke Extrcts (BSPK)
$0.0006+$0.0001 (+20.20%)
BSPK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.0001 (+20.20%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 134 | ||
30-Day Average Volume | 134 | ||
1-Week Change | 20.20% | ||
1-Month Change | 20.20% | ||
1-Year Change | -99.54% | ||
3-Year Change | -99.69% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 11.3M | ||
Total Assets | $295,573.00 | ||
Market Cap | $2.6M | ||
Enterprise Value | $3.9M | ||
Period: QTR TTM FY | |||
Revenue | $467,945.00 | ||
Net Income | -$78,088.00 | ||
Free Cash Flow | -$19,620.00 | ||
EBIT | -$67,382.00 | ||
EBITDA | -$64,329.00 | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -61 | ||
Enterprise Value/Revenue | 8 | ||
P/B | -1 | ||
P/E | -23 | ||
PEG | -0 | ||
Price/Free Cash Flow | -131 | ||
Price/Operating Cash Flow | -131 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 45 | ||
Last Split Date | 01/13/2023 | ||